Skip to main
HSIC

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 0%
Buy 45%
Hold 45%
Sell 9%
Strong Sell 0%

Bulls say

Henry Schein Inc. has demonstrated steady revenue growth across its various segments, with medical products revenue increasing by 4.7% and dental business revenue rising by 2.7%, signaling a solid demand for healthcare solutions. The global technology segment significantly contributed to this growth, generating $173 million in revenue and achieving a notable 9.7% increase, reflecting the company's effective integration of technology within its service offerings. Additionally, the anticipated mid-single digit growth in adjusted EBITDA for 2025 indicates a strong operational performance and financial health moving forward.

Bears say

Henry Schein Inc. reported a gross margin of 30.7%, falling short of the 31.6% expectation, primarily due to an unfavorable mix in its distribution and specialty products businesses, indicating challenges in maintaining profitability. Although the company experienced a slight increase in revenue in its Global Distribution and Value-Added Services segment, it remained below expectations, raising concerns about its growth trajectory in a competitive market. Furthermore, while adjusted EBITDA surpassed expectations, the overall performance metrics, including the decline in gross margin, suggest underlying weaknesses that may negatively impact long-term investor confidence in the stock.

Henry Schein (HSIC) has been analyzed by 11 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 45% recommend Buy, 45% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 11 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.